𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified phase II trial

✍ Scribed by Jeffrey C. Allen; Lawrence Helson; Berta Jereb

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
737 KB
Volume
52
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of neoadjuvant 1, 3-bis (
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma : A North American Brain Tumor Consortium trial
✍ Susan M. Chang; Michael D. Prados; W. K. Alfred Yung; Howard Fine; Larry Junck; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Abstract ## BACKGROUND Temozolomide (TMZ) and 1, 3‐bis (2‐chloroethyl)‐1‐nitrosourea (BCNU) are reported to be active agents in anaplastic glioma (AG). TMZ has also been shown to deplete alkyltransferase, a DNA repair enzyme that contributes to nitrosourea resistance. The objective of the curre

A multicentre phase II trial of gemcitab
A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03
✍ F. Hitz; G. Martinelli; E. Zucca; R. von Moos; W. Mingrone; M. Simcock; J. Peter πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Abstract Mantle cell lymphoma (MCL) has a poor prognosis with often short and incomplete remissions. We aimed to test the efficacy and tolerability of gemcitabine in treating MCL. Gemcitabine was given in doses of 1000 mg/m^2^ as a 30 min infusion on days 1 and 8 of each 3 week cycle for a maxim